Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models

Overview of attention for article published in Frontiers in immunology, July 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 35,333 followers.

RT @FrontImmunol: New Research: Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models: Pemphi…

Pleased and honored to be part of the team for this great piece of work #drugdevelopment #pemphigus https://t.co/RoSKEm4DOc @robylotti

RT @FrontImmunol: New Research: Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models: Pemphi…

RT @FrontImmunol: New Research: Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models: Pemphi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.